According to Hanmi Pharmaceutical
's latest financial reports the company has โน2.13 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | โน1.41 B | 35.73% |
2021-12-31 | โน1.04 B | 2.84% |
2020-12-31 | โน1.01 B | -4.14% |
2019-12-31 | โน1.05 B | -37.28% |
2018-12-31 | โน1.68 B | -26.78% |
2017-12-31 | โน2.29 B | -60.26% |
2016-12-31 | โน5.78 B | 8.32% |
2015-12-31 | โน5.33 B | 318.33% |
2014-12-31 | โน1.27 B | 238.8% |
2013-12-31 | โน0.37 B | -52.66% |
2012-12-31 | โน0.79 B | 115.68% |
2011-12-31 | โน0.36 B | -63.58% |
2010-12-31 | โน1.01 B | 0.8% |
2009-12-31 | โน1.00 B | -31.79% |
2008-12-31 | โน1.47 B | 90.67% |
2007-12-31 | โน0.77 B |